⚠️FOR RESEARCH PURPOSES ONLY
← Back to Research Database
ResearchPeptide

LL-37

Published Research

PubMed-indexed studies for LL-37

Research

LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity.

Pharmacological reports : PR 2016
View on PubMed →
Research

Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis.

Frontiers in immunology 2022
View on PubMed →
Research

Therapeutic Potential of Cathelicidin Peptide LL-37, an Antimicrobial Agent, in a Murine Sepsis Model.

International journal of molecular sciences 2020
View on PubMed →
Research

Cathelicidin peptide LL-37: A multifunctional peptide involved in heart disease.

Pharmacological research 2024
View on PubMed →
Research

Antimicrobial Peptide, LL-37, And Its Potential As An Anti-HIV Agent.

Clinical and investigative medicine. Medecine clinique et experimentale 2021
View on PubMed →
Research

Cathelicidin antimicrobial peptide expression in neutrophils and neurons antagonistically modulates neuroinflammation.

The Journal of clinical investigation 2024
View on PubMed →

Research-Grade LL-37

YPB.244
LL37 (5mg)
$60.00
⚠️ For laboratory research only. Not for human use.